Thiohydantoin derivatives incorporating a pyrazole core: Design, synthesis and biological evaluation as dual inhibitors of topoisomerase-I and cycloxygenase-2 with anti-cancer and anti-inflammatory activities-Reference-Cited by-同舟云学术

Thiohydantoin derivatives incorporating a pyrazole core: Design, synthesis and biological evaluation as dual inhibitors of topoisomerase-I and cycloxygenase-2 with anti-cancer and anti-inflammatory activities

Published:2019-10 Issue: Volume:91 Page:103132
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Abdellatif Khaled R.A.,Fadaly Wael A.A.,Mostafa Yaser A.,Zaher Dana M.,Omar Hany A.

Funder

Beni-Suef University, Egypt

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference35 articles.

1. M. De, K. Jessica, D.L. Glycinamide ribonucleotide transformylase (GAR TFase) as a target for cancer therapy, Boger, Drugs Future 33 (2008) 969–979.

2. Synthesis and evaluation of 1-benzhydryl-sulfonyl-piperazine derivatives as inhibitors of MDA-MB-231 human breast cancer cell proliferation;Kumar;Med. Chem. Res.,2007

3. Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention;Chan;Lancet Oncol.,2002

4. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues;Thun;J. Natl. Cancer Inst.,2002

5. G. Gasparini, R. Longo, R. Sarmiento, A. Morabito, Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? Lancet Oncol. 4 (2003) 605-615

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Delving into 5-Amino-3-(4-chlorophenyl)-1-isonicotinoyl-2,3-dihydro-1H-pyrazole-4-carbonitrile ligand: Synthesis, spectroscopic (FT-IR, FT-Raman, NMR, UV- Vis), reactivity (ELF, LOL and Fukui), NCI, molecular docking and in silico ADMET studies by experimental and DFT methods;Journal of Molecular Structure;2024-11

2. Development of New N- and S-substituted-imidazolidin-4-one Analogues with Potent Anti-breast Cancer Activity: In vitro Molecular Docking Assessment;Current Organic Chemistry;2024-09

3. Review of the recent advances of pyrazole derivatives as selective COX-2 inhibitors for treating inflammation;Molecular Diversity;2024-07-16

4. Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023);Expert Opinion on Therapeutic Patents;2024-07-03

5. Vicinal diaryl pyrazole with tetrazole/urea scaffolds as selective angiotensin converting enzyme‐1/cyclooxygenase‐2 inhibitors: Design, synthesis, anti‐hypertensive, anti‐fibrotic, and anti‐inflammatory;Drug Development Research;2024-06